Developing regenerative medicines at scale

At Stimuliver, we’re committed to supporting patients suffering from severe liver disease with a regenerative rescue treatment independent from donor organs.

What we do

Stimuliver safely supplements the liver’s functioning through a remote implant, which helps filter toxins and take the burden off the liver. It’s a radically different approach, which bypasses the need for donor tissue, with a ready-made, automated, scalable design.

Renewable

Off-the-shelf

Remote Regeneration

Learn More

About Stimuliver

Founded by researchers David Hay and Dagmara Szkolnicka at the University of Edinburgh, Stimuliver aims to develop a groundbreaking therapy for liver diseases with limited treatment options. Our vision is to revolutionize the field by creating an innovative solution that addresses the critical need for effective therapies.

Through cutting-edge research and unwavering determination, we strive to provide new hope for individuals suffering from liver ailments.

LEARN MORE

Meet the team

Teamwork is crucial at Stimuliver. By collaborating, we leverage diverse skills, create a positive work environment, tackle projects efficiently, and promote growth. It's the foundation of our success.